How low should you go with LDL cholesterol lowering in secondary prevention?: clinical efficacy andsafety in the era of PCSK9 inhibitors
B. Cybulska
L. Kłosiewicz-Latoszek
Peter E. Penson
S. Nabavi
Maciej Banach
B. Cybulska
Maciej Banach
· 0 citations
· 76 references